日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosis

可溶性尿激酶型纤溶酶原激活物受体是失代偿期肝硬化的预后生物标志物。

Lamatsch, Sven; Hassan, Mohsin; Kappert, Kai; Berger, Hilmar; Bai, Qingquan; Zhao, Zhengyang; Walia, Nirbaanjot; De La Peña-Ramirez, Carlos; Mohr, Raphael; Demir, Münevver; Wang, Juan; Artusa, Fabian; Sittner, Richard; Andreola, Fausto; Veelken, Rhea; van Boemmel, Florian; Schumacher, Jonas; Aehling, Niklas; Fischer, Janett; Mookerjee, Rajeshwar; Hu, Tianhui; Berg, Thomas; Jalan, Rajiv; Tacke, Frank; Kumar, Pavitra; Engelmann, Cornelius

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

单细胞RNA测序衍生的特征谱定义了晚期肝细胞癌对阿特珠单抗+贝伐珠单抗的反应模式

Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M

HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

HLA-A*01:01-B*08:01-C*07:01 与早期发病的免疫检查点抑制剂诱发的肌炎和心肌炎相关。

Müller-Jensen, Leonie; Flatz, Lukas; Hasan Ali, Omar; Mohr, Raphael; Lachmann, Nils; Mödl, Lukas; Endres, Matthias; Boehmerle, Wolfgang; Huehnchen, Petra

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

评估接受阿特珠单抗和贝伐珠单抗一线免疫治疗的肝细胞癌患者的预后评分

Gairing, Simon Johannes; Mildenberger, Philipp; Gile, Jennifer; Artusa, Fabian; Scheiner, Bernhard; Leyh, Catherine; Lieb, Sabine; Sinner, Friedrich; Jörg, Vincent; Fruendt, Thorben; Himmelsbach, Vera; Abedin, Nada; Sahin, Cennet; Böttcher, Katrin; Schuhbaur, Jasmin; Labuhn, Simon; Korolewicz, James; Fulgenzi, Claudia A M; D'Alessio, Antonio; Zanuso, Valentina; Hucke, Florian; Röhlen, Natascha; Ben Khaled, Najib; Ramadori, Eleonora; Müller, Lukas; Weinmann, Arndt; Kloeckner, Roman; Galle, Peter Robert; Tran, Nguyen H; Venkatesh, Sudhakar K; Teufel, Andreas; Ebert, Matthias; De Toni, Enrico N; Waldschmidt, Dirk-Thomas; Marquardt, Jens U; Bettinger, Dominik; Peck-Radosavljevic, Markus; Geier, Andreas; Reiter, Florian P; Rimassa, Lorenza; Pinato, David J; Roderburg, Christoph; Ettrich, Thomas; Bitzer, Michael; Scheble, Veit; Ehmer, Ursula; Berres, Marie-Luise; Finkelmeier, Fabian; Gonzalez-Carmona, Maria Angeles; von Felden, Johann; Schulze, Kornelius; Venerito, Marino; van Bömmel, Florian; Jochheim, Leonie S; Pinter, Matthias; Mohr, Raphael; Ilyas, Sumera I; Schmidtmann, Irene; Foerster, Friedrich

Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma

不可切除肝细胞癌局部区域治疗的免疫学效应

Schmidt, Robin; Gebauer, Bernhard; Akbari, Nilufar; Roderburg, Christoph; Torsello, Giovanni Federico; Fehrenbach, Uli; Auer, Timo Alexander; Mohr, Raphael; Ardila Pardo, Gracia Lana; Lim, Winna; Pivetta, Fabio; Can, Elif; Hamm, Charlie Alexander; Tacke, Frank; Hamm, Bernd; Hammerich, Linda; Savic, Lynn Jeanette

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma

可溶性尿激酶型纤溶酶原激活物受体可预测晚期肝细胞癌患者的生存期和肝功能失代偿

Artusa, Fabian; Lamatsch, Sven; Phan, Minh Duc; Özdirik, Burcin; Berger, Hilmar; Egerer, Mara; Knorr-Klocke, Jana; Fischer, Janett; Veelken, Rhea; van Bömmel, Florian; Berg, Thomas; Kappert, Kai; Tauber, Rudolf; Puengel, Tobias; Engelmann, Cornelius; Demir, Münevver; Tacke, Frank; Mohr, Raphael

CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosis

CT引导下高剂量率近距离放射治疗消融伴门静脉癌栓的肝细胞癌患者

Auer, Timo Alexander; Ranner-Hafferl, Marie-Luise Helene Hildegard; Anhamm, Melina; Böning, Georg; Fehrenbach, Uli; Mohr, Raphael; Geisel, Dominik; Kloeckner, Roman; Gebauer, Bernhard; Collettini, Federico

Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population

吉西他滨/顺铂联合度伐利尤单抗治疗晚期胆道癌——来自德国多中心患者人群的真实世界数据

Gerhardt, Florian; Müller, Christian; Venerito, Marino; Chater, Jack; Mohr, Raphael; Egerer, Mara; Lindig, Udo; Schindler, Aaron; Ebel, Sebastian; Fischer, Janett; Schwarz, Maik; Gehring, Sonja; Berg, Thomas; van Bömmel, Florian

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

方案:粪便微生物群移植治疗肝癌以克服对阿特珠单抗/贝伐珠单抗的耐药性——一项多中心、随机、安慰剂对照、双盲 II 期试验(FLORA 试验)

Rauber, Conrad; Roberti, Maria Paula; Vehreschild, Maria Jgt; Tsakmaklis, Anastasia; Springfeld, Christoph; Teufel, Andreas; Ettrich, Thomas; Jochheim, Leonie; Kandulski, Arne; Missios, Pavlos; Mohr, Raphael; Reichart, Alexander; Waldschmidt, Dirk T; Sauer, Lukas D; Sander, Anja; Schirmacher, Peter; Jäger, Dirk; Michl, Patrick; Dill, Michael T

Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.

检查点抑制剂诱导自身免疫的免疫特征——以神经毒性为重点

Müller-Jensen Leonie, Schulz Axel R, Mei Henrik E, Mohr Raphael, Ulrich Claas, Knape Philipp, Frost Nikolaj, Frischbutter Stefan, Kunkel Desiree, Schinke Christian, Ginesta Roque Lorena, Maierhof Smilla K, Nickel Florian T, Heinzerling Lucie, Endres Matthias, Boehmerle Wolfgang, Huehnchen Petra, Knauss Samuel